Form 4 · Filed May 28, 2026, 01:13 PM UTC
GALT/GALECTIN THERAPEUTICS INC
Jamil Khurram — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 26, 2026 | M | other | 568 | $1 | $699 | 568 |
| May 26, 2026 | S | sell | 568 | $3 | $1,761 | 0 |
| May 26, 2026 | M | other | 568 | — | — | 40,057 |
Source: SEC EDGAR raw filing ↗ · Accession 0001133416-26-000055